Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Robert Desantis Sells 1,012 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Robert Desantis sold 1,012 shares of Intuitive Surgical stock in a transaction on Friday, October 25th. The stock was sold at an average price of $514.00, for a total transaction of $520,168.00. Following the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,830,084. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Robert Desantis also recently made the following trade(s):

• On Tuesday, October 29th, Robert Desantis sold 188 shares of Intuitive Surgical stock. The stock was sold at an average price of $506.52, for a total transaction of $95,225.76.
• On Tuesday, September 10th, Robert Desantis sold 238 shares of Intuitive Surgical stock. The shares were sold at an average price of $477.50, for a total transaction of $113,645.00.
• On Thursday, August 29th, Robert Desantis sold 188 shares of Intuitive Surgical stock. The stock was sold at an average price of $482.21, for a total value of $90,655.48.
• On Monday, August 26th, Robert Desantis sold 396 shares of Intuitive Surgical stock. The shares were sold at an average price of $486.88, for a total value of $192,804.48.
• On Monday, August 12th, Robert Desantis sold 240 shares of Intuitive Surgical stock. The shares were sold at an average price of $464.76, for a total value of $111,542.40.

Intuitive Surgical Price Performance

ISRG stock opened at $516.31 on Wednesday. Intuitive Surgical, Inc. has a 1 year low of $254.85 and a 1 year high of $523.34. The firm has a market capitalization of $183.90 billion, a P/E ratio of 83.01, a P/E/G ratio of 5.11 and a beta of 1.39. The business’s 50-day moving average is $489.22 and its two-hundred day moving average is $444.82.

Institutional Trading of Intuitive Surgical

Several hedge funds have recently added to or reduced their stakes in the company. Creekmur Asset Management LLC increased its holdings in shares of Intuitive Surgical by 200.0% in the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 42 shares during the last quarter. Ridgewood Investments LLC acquired a new position in Intuitive Surgical in the second quarter valued at $26,000. Delos Wealth Advisors LLC boosted its position in shares of Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 57 shares during the period. Godsey & Gibb Inc. increased its position in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares during the period. Finally, LRI Investments LLC acquired a new position in Intuitive Surgical during the first quarter worth approximately $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. JPMorgan Chase & Co. boosted their price target on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Citigroup boosted their target price on shares of Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. Wells Fargo & Company raised their price target on shares of Intuitive Surgical from $466.00 to $549.00 and gave the stock an “overweight” rating in a report on Friday, October 18th. Royal Bank of Canada increased their target price on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. Finally, The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a research note on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $513.74.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.